Skip to content

Drug interactions

Blinatumomab + Warfarin

Severity: Moderate

Blinatumomab and Warfarin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Blinatumomab causes transient cytokine release that can suppress CYP450 enzyme activity. Warfarin levels and anticoagulant effect may rise, increasing bleeding risk, mainly at treatment initiation.

What this interaction means in plain words

Blinatumomab and Warfarin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Blinatumomab belongs to Oncology; Warfarin belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Cytokine release (e.g. IL-6) temporarily downregulates hepatic CYP450 enzymes, reducing warfarin metabolism.

What to do

Monitor INR more frequently during the first days of the first cycle and when restarting after interruption. Adjust warfarin dose accordingly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Blinatumomab and Warfarin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Blinatumomab with Warfarin?

MediHelp rates the interaction as moderate. Blinatumomab and Warfarin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Blinatumomab causes transient cytokine release that can suppress CYP450 enzyme activity. Warfarin levels and anticoagulant effect may rise, increasing bleeding risk, mainly at treatment initiation.

How serious is the interaction between Blinatumomab and Warfarin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor INR more frequently during the first days of the first cycle and when restarting after interruption. Adjust warfarin dose accordingly.

What other medicines interact with Blinatumomab?

MediHelp also lists interactions of Blinatumomab with, for example, Carbamazepine, Cyclosporin, Ethosuximide. The full list is on the Blinatumomab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in